기본 정보
- CAS
33876-97-0- 표준 SMILES
N=c1c[n+](N2CCOCC2)[n-]o1- InChIKey
FKDHHVKWGRFRTG-UHFFFAOYSA-N- 분자식
- C6H10N4O2
- 평균 분자량
- 170.17 g/mol
- 단동위원소 질량
- 170.08037557
개요
Linsidomine is a member of morpholines.
이름 및 식별자
- 우선 이름
- Linsidomine
- IUPAC
- 3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine
- 현지명
- 3-모르폴리노시드노니민
- 영어명
- 3-MORPHOLINOSYDNONIMINE
- 분자식
- C6H10N4O2
- 분자량
- 170.17
이름 및 동의어
Linsidomine33876-97-03-Morpholinosydnone imineLinsidominaLinsidominumsin-13-MorpholinosydnoneimineCV 6645O5U71P6VQDTXSID501026026N-morpholino sydnonimine3-Morpholino-sydnonimine
이름 더 보기
3-모르폴리노시드노니민cv6643-MorpholinosydnonmineHCl3-Morpholinosydnone imine-3-ium3-MorpholinosydnonminehydrochlorideMolsidomine EP Impurity A(linsidomine)Molsidomine Impurity 1 (Molsidomine EP Impurity A)3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine
SIN-1 morpholineCV-6643-morpholinosydonimineRefChem:153577C01DX18DTXCID4015102745-azanidyl-3-(morpholin-4-yl)-1,2,3lambda5-oxadiazol-3-ylium3-MORPHOLINOSYDNONIMINE
데이터베이스 식별자
- CAS
33876-97-0- PubChem CID
- 5219
- DTXSID
DTXSID501026026- ChEMBL
CHEMBL1189150- ChEBI
CHEBI:136004- UNII
- 5O5U71P6VQ
- Nikkaji
- J314.096B
물성
구조 계산 물성
- XLogP
- 0.6
- 극성 표면적
- 49.6 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 5
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 12
- 형식 전하
- 0
- 복잡도
- 222
물리화학적 성질
- 저장 조건
- 20 °C · −20°C
- 용해도
- 2 O: · H2O: >10 mg/mL
- 물리적 상태
- 고체
- 색상
- 회백색
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
안전 데이터
- wgk
- 3
화학 및 산업
약리 정보
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Drugs used to cause dilation of the blood vessels.
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)
응용 분야
용도3-Morpholinosydnonimine is a potent vasodilator that inhibits platelet aggregation and cysteine proteases.
공급사14 곳
湖北永阔科技有限公司027-59223108 15972152991 · [email protected]
安耐吉化学&3A（安徽泽升科技有限公司）021-58432009 400-005-6266 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
青岛海智微元生物科技有限公司18317699790 18317699790 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
厦门志信化学有限公司+86-5922680277 +86-13806087780 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
武汉峰耀同辉化学制品有限公司027-87466105 15377573527 · [email protected]
Hefei Hirisun Pharmatech Co., Ltd+8615056975894 · [email protected]
Mainchem Co., Ltd.+86-86-05926210733 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
Hefei TNJ Chemical Industry Co.,Ltd.+86-0551-65418671 +86-189 4982 3763 · [email protected]
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…